[Pharmacologic study with glisoxepide and other blood sugar reducing sulfonamide derivatives in metabolically healthy subjects and diabetics].
D000284:Administration, Oral; D001322:Autoanalysis; D001381:Azepines / Q000008:administration & dosage / Q000494:pharmacology*; D001786:Blood Glucose / Q000032:analysis*; D003864:Depression, Chemical; D003920:Diabetes Mellitus / Q000378:metabolism*; D004305:Dose-Response Relationship, Drug; D004341:Drug Evaluation; D005905:Glyburide / Q000008:administration & dosage / Q000494:pharmacology; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000494:pharmacology*; D007275:Injections, Intravenous; D007328:Insulin / Q000097:blood; D010080:Oxazoles / Q000008:administration & dosage / Q000494:pharmacology*; D013449:Sulfonamides / Q000494:pharmacology*; D013453:Sulfonylurea Compounds / Q000008:administration & dosage / Q000494:pharmacology*; D013997:Time Factors; D014044:Tolbutamide / Q000008:administration & dosage / Q000494:pharmacology
D001381:Azepines; D001786:Blood Glucose; D007004:Hypoglycemic Agents; D007328:Insulin; D010080:Oxazoles; D013449:Sulfonamides; D013453:Sulfonylurea Compounds; D014044:Tolbutamide; D005905:Glyburide
Pharmakologische Untersuchungen mit Glisocepid und anderen blutzuckersenkenden Sulfonamidderivaten an Stoffwechselgesunden und Diabetikern